2022
DOI: 10.21203/rs.3.rs-1465550/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Effect of Lugol’s solution on 131 I therapy efficacy in Graves’ disease

Abstract: Purpose Lugol’s solution could control thyroid function and suppress 131I uptake in hyperthyroidism. This study aimed to investigate the appropriate time to withdraw Lugol’s solution before 131I therapy (RIT) in Graves’ disease (GD) patients, and how this should influence thyrotropin receptor antibodies (TRAb), 131I uptake and RIT outcome.Methods Two groups (125 cases and 1805 cases) of GD patients reveived RIT, who were pre-treated with and without Lugol’s solution (RI-CI group and RI group). The RI-CI group … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The thyroid radioactivity uptake was calculated using background radiation correction and a reference standard: thyroid uptake=(neck counts-the remainder of the body counts)/(reference counts-room counts). The RAIU of the thyroid was determined dynamically at 24, 48, and 72 h to determine the highest RAIU (RAIUmax) and Tef (18).…”
Section: Serum Hormone Measurements and Raiu Assaysmentioning
confidence: 99%
“…The thyroid radioactivity uptake was calculated using background radiation correction and a reference standard: thyroid uptake=(neck counts-the remainder of the body counts)/(reference counts-room counts). The RAIU of the thyroid was determined dynamically at 24, 48, and 72 h to determine the highest RAIU (RAIUmax) and Tef (18).…”
Section: Serum Hormone Measurements and Raiu Assaysmentioning
confidence: 99%